medigraphic.com
SPANISH

Revista de Ciencias Médicas de Pinar del Río

ISSN 1561-3194 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 2

<< Back Next >>

Rev Ciencias Médicas 2020; 24 (2)

Coats disease

Jalilo HSM, Santander AR, Gómez MN
Full text How to cite this article

Language: Spanish
References: 13
Page: 1-6
PDF size: 215.55 Kb.


Key words:

Coats disease, telangiectasias, diagnosis.

ABSTRACT

Introduction: Coats disease is a rare, idiopathic retinal vasculopathy that can progress to exudative retinal detachment and neovascular glaucoma. Typically occurring in childhood, it is the third most common cause of childhood leukocoria.
Case report: Patient masculine of two years of age, coming from rural area. You attended consultation, because he/she suckles her he/she noticed that the boy deviates the right eye toward it was since he was born.
Conclusions: Coats disease simulates other retinal vasculopathies and retinoblastoma. The behavior to be followed will depend on the clinical form of presentation and associated complications.


REFERENCES

  1. Fernandes H, Umashankar T, Richie AJ, Hegde S. Coats - enfermedad de los ojos rara vez encontrada por patólogos. Indian J Pathol Microbiol [Internet] 2018 [citado el 18/05/2019]; 61(1): [aprox. 2p.]. Disponible en: Disponible en: http://www.ijpmonline.org/text.asp?2018/61/1/98/228199

  2. Andonegui J, Aranguren M, Berástegui L. Coats disease of adult onset. Arch Soc Esp Oftalmol [Internet]. 2008 Feb [citado 01/07/2019]; 83(2): [aprox. 3p.]. Disponible en: Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912008000200010&lng=es

  3. lvarez-Rivera LG, Abraham-Marín ML, Flores-Orta HJ, Mayorquín-Ruiz M, Cortés-Luna CF. Coat's disease treated with bevacizumab (Avastin®). Arch Soc Esp Oftalmol [Internet]. 2008 Mayo [citado 01/07/2019]; 83(5): [aprox. 2p.]. Disponible en: Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912008000500010

  4. Sein J, Tzu J, Murray T, Berrocal A. Treatment of Coats' Disease With Combination Therapy of Intravitreal Bevacizumab, Laser Photocoagulation, and Sub-Tenon Corticosteroids. Ophthalmic Surg Lasers Imaging Retina [Internet] 2016 [citado el 18/05/2019]; 47(5): [aprox. 6p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27183548

  5. Ryan SJ, Retina MR. Enfermedades vasculares retinianas. Sección II: Enfermedad de Coats. Madrid: Editorial Marbán Libros; 2013. p. 1058-1069.

  6. Sigler EJ, Randolph JC, Calzada JI, Wilson MW, Haik BG. Current management of Coats’ disease. Surv Ophthalmol [Internet]. 2014 [citado el 18/05/2019]; 59(1): [aprox. 16p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24138893

  7. Villegas VM, Gold AS, Berrocal AM, Murray TG. Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation. Clin Ophthalmol [Internet] 2014 [citado el 18/05/2019]; 8: [aprox. 3p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037307/

  8. Suesskind D, Altpeter E, Schrader M, Bartz-Schmidt KU, Aisenbrey S. Pars plana vitrectomy for treatment of advanced Coats’ disease-presentation of a modified surgical technique and long-term follow-up. Graefes Arch Clin Exp Ophthalmol [Internet] 2014 [citado el 18/05/2019]; 252(6): [aprox. 6p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24218042

  9. Bhat V, D’Souza P, Shah PK, Narendran V. Risk of tractional retinal detachment following intravitreal bevacizumab along with subretinal fluid drainage and cryotherapy for stage 3B Coats’ disease. Middle East Afr J Ophthalmol [Internet] 2016 [citado el 18/05/2019]; 23(2): [aprox. 3p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27162454

  10. Karacorlu M, Hocaoglu M, Sayman M, Arf S. Long-term anatomical and functional outcomes following vitrectomy for advanced Coats disease. Retina [Internet] 2017 [citado el 18/05/2019]; 37(9): [aprox. 7p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27984550

  11. Peng J, Zhang Q, Jin H, Fei P, Zhao P. A modified technique for the transconjunctival and sutureless external drainage of subretinal fluid in bullous exudative retinal detachment using a 24-G i.v. catheter. Ophthalmologica [Internet]. 2017 [citado el 18/05/2019]; 238(4): [aprox. 6p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28866667

  12. Grosso A, Pellegrini M, Cereda MG, Panico C, Staurenghi G, Sigler EJ. Pearls and pitfalls in diagnosis and management of Coats disease. Retina [Internet]. 2015 [citado el 18/05/2019]; 35(4): [aprox. 9p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25811949

  13. Abujamra S. Telangiectasias perimaculares idiopáticas. Rev. bras. oftalmol [Internet]. 2012 Aug [cited 21/03/2019]; 71(4): [aprox. 3p.]. Disponible en: Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802012000400001&lng=en




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Ciencias Médicas. 2020;24